SEKORIE Trademark

Trademark Overview

On Friday, September 6, 2019, a trademark application was filed for SEKORIE with the United States Patent and Trademark Office. The USPTO has given the SEKORIE trademark a serial number of 88607443. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 11, 2023. This trademark is owned by Janssen Sciences Ireland Unlimited Company. The SEKORIE trademark is filed in the Pharmaceutical Products category with the following description:

Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; anti-allergics; anti-infectives; excluding pharmaceutical preparations for the treatment of oncological diseases and disorders
sekorie

General Information

Serial Number88607443
Word MarkSEKORIE
Filing DateFriday, September 6, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 11, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 10, 2019

Trademark Statements

Goods and ServicesHuman pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; anti-allergics; anti-infectives; excluding pharmaceutical preparations for the treatment of oncological diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 18, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameJanssen Sciences Ireland Unlimited Company
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressRingaskiddy, Co. Cork
IE
Party NameJanssen Sciences Ireland Unlimited Company
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressRingaskiddy, Co. Cork
IE

Trademark Events

Event DateEvent Description
Monday, September 11, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, September 11, 2023ABANDONMENT - NO USE STATEMENT FILED
Saturday, February 25, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 24, 2023SOU EXTENSION 5 GRANTED
Tuesday, February 7, 2023SOU EXTENSION 5 FILED
Friday, February 24, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, February 7, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, August 2, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 29, 2022SOU EXTENSION 4 GRANTED
Friday, July 29, 2022SOU EXTENSION 4 FILED
Friday, July 29, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, February 2, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 31, 2022SOU EXTENSION 3 GRANTED
Monday, January 31, 2022SOU EXTENSION 3 FILED
Monday, January 31, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, February 1, 2022ASSIGNED TO EXAMINER
Thursday, July 29, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 27, 2021SOU EXTENSION 2 GRANTED
Tuesday, July 27, 2021SOU EXTENSION 2 FILED
Tuesday, July 27, 2021SOU TEAS EXTENSION RECEIVED
Friday, November 6, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 4, 2020SOU EXTENSION 1 GRANTED
Wednesday, November 4, 2020SOU EXTENSION 1 FILED
Wednesday, November 4, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, August 11, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, June 26, 2020CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Tuesday, June 23, 2020ASSIGNED TO PETITION STAFF
Thursday, June 18, 2020EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Wednesday, May 27, 2020TEAS POST PUBLICATION AMENDMENT RECEIVED
Thursday, January 2, 2020EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, December 10, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 10, 2019PUBLISHED FOR OPPOSITION
Wednesday, November 20, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, November 4, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, November 1, 2019ASSIGNED TO EXAMINER
Wednesday, September 18, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 10, 2019NEW APPLICATION ENTERED

Related Keywords

sekorie diseases system treatment anti pharmaceutical preparations digital ulcers respiratory ophthalmic